Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use.
about
Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsComparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children witPostantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciIn vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).Antipneumococcal activity of ABT-773 compared to those of 10 other agents.In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniaeKilling activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologiesEfficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchillaComparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptibleTrovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents.Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.Cefotaxime breakpoint for Streptococcus pneumoniae.Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.Testing of Streptococcus pneumoniae for resistance to penicillinDetection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniaePneumococcal resistance to antimicrobial agents in the province of Québec, Canada.Circulating Serotypes and Trends in Antibiotic Resistance of Invasive Streptococcus Pneumoniae from Children under Five in Bangalore.Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.Therapy of penicillin- and cephalosporin-resistant pneumococcal infections.The acquisition of antibiotic resistance in the periodontal microflora.Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis.Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96.
P2860
Q33672446-36B1F41B-CEA0-494B-93BD-30BF2CF08F39Q33691239-2DBC6C9E-3E05-4964-9369-C63D2794E8B5Q33692927-7DB07A62-80F4-4278-8B1A-E67FFBA274C1Q33696032-9AB4AC4F-C1A5-420E-ACDC-BBC7C0DE6C5CQ33976567-4DEE1120-5691-4FED-8909-8B97B7F75B36Q33980037-BCA7F2C2-0D2F-445B-9C26-2819333B4FA1Q35117123-D682230A-B89A-4715-81C7-D858AD3C82D7Q35120392-A076F856-7B17-435E-90FA-8D8FB7586777Q35123654-902E83FA-288C-41F5-8A1E-163696ECB905Q35124415-FC89BDEC-4E75-4D06-8BC8-41F7B7D4BD22Q35125580-B81F9534-7A74-4DB1-AA9A-F1A1D6401706Q35126162-054D9CA0-43EC-48E4-808E-EC893DD5A499Q35126352-36AE0CE7-365E-4C06-8B13-F06D3CA2A34DQ35126660-DBF16969-8948-463E-B824-62687EE77521Q35133005-AAB5E01B-DD9F-4F1A-9E60-424D9B79CEE4Q35135982-4DAA4BDA-2D45-4FCD-9B2D-5A8ACD482C7EQ35137932-14A6F3DC-80E0-4AE4-9522-0DC17FE46A20Q35810802-3F811E4C-57BE-4F4F-BAE5-69148816D75EQ35817800-9B43E202-4FA9-423A-91AF-DC6076183F5BQ35818575-545E9929-9769-4E1A-87C5-69669EE2FB02Q35822592-2FFD6257-DEF1-4443-84E3-E84EFA7202D1Q37068088-F8850EFA-9BF7-4761-9F00-D7DA753A3020Q37070023-627E56F3-452C-4F45-9863-30579A5561EDQ37071655-A6A979C9-7CC5-4036-97F6-192B91D80E29Q37093797-3C4D38A2-E6D8-4C98-A5F2-F1F95790DEB6Q37094351-171C5200-97CA-498C-8EB2-17A555756BDEQ37573206-2A79CA6C-A7EF-4AD6-B756-00BC1DEAD98AQ39781217-FB1FABDF-6434-4738-BE7D-71427E3DEC36Q40785357-9C3B9122-CF1D-40BC-8E0B-20A85FE0FDE8Q41754773-CB4F35AA-53A9-4495-AE3B-3F016C2DD856Q52239946-A7A56508-A916-4333-9B1A-A49B54D47C15Q54116795-C9B34EE1-9F0C-4E7D-82FF-C9093FE5B214
P2860
Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Increased rate of isolation of ...... of potential therapeutic use.
@ast
Increased rate of isolation of ...... of potential therapeutic use.
@en
type
label
Increased rate of isolation of ...... of potential therapeutic use.
@ast
Increased rate of isolation of ...... of potential therapeutic use.
@en
prefLabel
Increased rate of isolation of ...... of potential therapeutic use.
@ast
Increased rate of isolation of ...... of potential therapeutic use.
@en
P2093
P2860
P356
P1476
Increased rate of isolation of ...... of potential therapeutic use.
@en
P2093
Lamberth LB
Mason EO Jr
P2860
P304
P356
10.1128/AAC.36.8.1703
P407
P577
1992-08-01T00:00:00Z